Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies

E Carnero Contentti, J Correale - Journal of neuroinflammation, 2021 - Springer
Neuromyelitis optica (NMO) is a chronic inflammatory autoimmune disease of the central
nervous system (CNS) characterized by acute optic neuritis (ON) and transverse myelitis …

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD)–revised recommendations of the Neuromyelitis Optica Study Group …

T Kümpfel, K Giglhuber, O Aktas, I Ayzenberg… - Journal of …, 2024 - Springer
This manuscript presents practical recommendations for managing acute attacks and
implementing preventive immunotherapies for neuromyelitis optica spectrum disorders …

Neuromyelitis optica spectrum disorders

F Costello - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
PURPOSE OF REVIEW This article reviews the cardinal clinical features, distinct
immunopathology, current diagnostic criteria, relapse-related risk factors, emerging …

Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care

G Fadda, T Armangue, Y Hacohen, T Chitnis… - The Lancet …, 2021 - thelancet.com
The field of acquired CNS neuroimmune demyelination in children is transforming. Progress
in assay development, refinement of diagnostic criteria, increased biological insights …

A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course

JM Solomon, F Paul, C Chien, J Oh… - Therapeutic …, 2021 - journals.sagepub.com
Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, inflammatory disease of the
central nervous system marked by relapses often associated with poor recovery and long …

Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders

V Camera, S Messina, KT Elhadd… - Journal of Neurology …, 2022 - jnnp.bmj.com
Objective To describe onset clinical features predicting time to first relapse and time to long-
term visual, motor and cognitive disabilities in paediatric-onset aquaporin-4 antibody (AQP4 …

Safety and efficacy of plasma exchange treatment in children with AQP4-IgG positive neuromyelitis optica spectrum disorder

Z Li, L Wan, X Liu, J Wang, X Shi, H Zhou… - Frontiers in …, 2023 - frontiersin.org
Neuromyelitis optica spectrum disorder (NMOSD), a severe demyelinating disease, is rare
among children. Plasma exchange (PE) is widely used as a salvage therapy for severe and …

Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder

DM Wingerchuk, BG Weinshenker… - Journal of managed …, 2022 - jmcp.org
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune
disorder affecting the central nervous system that is associated with significant morbidity and …

Advances in the long-term treatment of neuromyelitis optica spectrum disorder

M Anderson, M Levy - Journal of Central Nervous System …, 2024 - journals.sagepub.com
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune neuroinflammatory
disorder with a prevalence of 1-5/100,000 globally, characterized by attacks of the central …

Pediatric neuromyelitis optica spectrum disorder: case series and literature review

MAN Ferilli, R Paparella, I Morandini, L Papetti… - Life, 2021 - mdpi.com
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a central nervous system (CNS)
inflammatory demyelinating disease characterized by recurrent inflammatory events that …